Home Trending Vaccine-Related Headlines Trending Substack vaccine-related content Be careful with the GLP-1s agonists e.g. Pfizer now ends its clinical trial an of oral GLP-1 drug called danuglipron. The statement suggests that the patient’s liver enzymes were elevated which often